SearchDictionaryMobileLogin

Veena Charu Selected Research

Anemia

10/2007A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia.
06/2007Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: a controlled, randomized, open-label phase II trial.
07/2006Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia.
12/2005Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly.
01/2004A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.
07/2003Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks.
10/2002Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.

Articles by Research Topic

Disease

7Anemia
10/2007 - 10/2002
5Neoplasms (Cancer)
12/2007 - 07/2003
2Nausea
09/2006 - 12/2003
2Vomiting
09/2006 - 12/2003
1Breast Neoplasms (Breast Cancer)
12/2005
1Fatigue
07/2003

Drug/Important Bio-Agent (IBA)

7darbepoetin alfa (Aranesp)FDA Link
10/2007 - 10/2002
4Epoetin Alfa (Epogen)FDA Link
07/2006 - 01/2004
2palonosetron (Aloxi)FDA Link
09/2006 - 12/2003
1pegfilgrastim (Neulasta)FDA Link
12/2007
1Dexamethasone (Maxidex)FDA LinkGeneric
09/2006
1aprepitant (Emend)FDA Link
09/2006
15-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
12/2003
1dolasetron mesylate (dolasetron)FDA Link
12/2003

Therapy/Procedure

10Drug Therapy (Chemotherapy)
12/2007 - 10/2002